General Announcement::Lonza Opens World's Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in Pearland, USA

Issuer & Securities

Issuer/ Manager
LONZA GROUP LTD
Securities
LONZA GROUP LTD - CH0013841017 - O6Z
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
11-Apr-2018 11:13:09
Status
New
Announcement Sub Title
Lonza Opens World's Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in Pearland, USA
Announcement Reference
SG180411OTHR709M
Submitted By (Co./ Ind. Name)
Esther Au
Designation
SGXNet Authorised User
Description (Please provide a detailed description of the event in the box below)
Please see attached news release.

Attachments